MMDPPA
MMDPPA is an amphetamine and is a precursor in the synthesis of MDA[1].
Product Specifications
CAS Number
858215-05-1
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Related Pathways
Others
Field of Research
Neurological Disease
Smiles
O=C(N)C(C)CC1=CC=C(OCO2)C2=C1
Molecular Formula
C11H13NO3
Molecular Weight
207.23
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Haarberg HE, et al. Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma. Mol Cancer Ther. 2013 Jun;12 (6) :901-12.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1186556-01 0.02 mg (E-Coli)
Recombinant Human Putative beta-lactamase-like 1 (LACTBL1)
Sign In for Pricing
View Details MBS1186556-02 0.02 mg (Yeast)
Recombinant Human Putative beta-lactamase-like 1 (LACTBL1)
Sign In for Pricing
View Details MBS1186556-03 0.1 mg (E-Coli)
Recombinant Human Putative beta-lactamase-like 1 (LACTBL1)
Sign In for Pricing
View Details MBS1186556-04 0.1 mg (Yeast)
Recombinant Human Putative beta-lactamase-like 1 (LACTBL1)
Sign In for Pricing
View Details MBS1186556-05 0.02 mg (Baculovirus)
Recombinant Human Putative beta-lactamase-like 1 (LACTBL1)
Sign In for Pricing
View Details MBS1186556-06 0.02 mg (Mammalian-Cell)
Recombinant Human Putative beta-lactamase-like 1 (LACTBL1)
Sign In for Pricing
View Details